140 related articles for article (PubMed ID: 6745430)
1. Thymidylate synthetase-positive and -negative murine mammary FM3A carcinoma cells as a useful system for detecting thymidylate synthetase inhibitors.
Balzarini J; de Clercq E; Ayusawa D; Seno T
FEBS Lett; 1984 Jul; 173(1):227-32. PubMed ID: 6745430
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of 5-substituted pyrimidine nucleoside analogues into DNA of a thymidylate synthetase-deficient murine FM3A carcinoma cell line.
Balzarini J; De Clercq E; Ayusawa D; Seno T
Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):19-28. PubMed ID: 3990443
[TBL] [Abstract][Full Text] [Related]
3. Thymidylate synthetase-deficient mouse FM3A mammary carcinoma cell line as a tool for studying the thymidine salvage pathway and the incorporation of thymidine analogues into host cell DNA.
Balzarini J; De Clercq E; Ayusawa D; Seno T
Biochem J; 1984 Jan; 217(1):245-52. PubMed ID: 6696722
[TBL] [Abstract][Full Text] [Related]
4. 5-Substituted 2'-deoxyuridines: correlation between inhibition of tumor cell growth and inhibition of thymidine kinase and thymidylate synthetase.
Balzarini J; De Clercq E; Mertes MP; Shugar D; Torrence PF
Biochem Pharmacol; 1982 Nov; 31(22):3673-82. PubMed ID: 7181950
[TBL] [Abstract][Full Text] [Related]
5. Modulation of anti-metabolite effects. Effects of thymidine on the efficacy of the quinazoline-based thymidylate synthetase inhibitor, CB3717.
Jackman AL; Taylor GA; Calvert AH; Harrap KR
Biochem Pharmacol; 1984 Oct; 33(20):3269-75. PubMed ID: 6487375
[TBL] [Abstract][Full Text] [Related]
6. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
[TBL] [Abstract][Full Text] [Related]
7. Role of thymidine kinase and thymidylate synthetase in the cytostatic, antimetabolic, and antitumor effects of the carbocyclic analogue of 5-nitro-2'-deoxyuridine. A comparison with 5-nitro-2'-deoxyuridine.
Balzarini J; De Clercq E; Herdewijn P; Robins MJ
Mol Pharmacol; 1985 May; 27(5):578-83. PubMed ID: 3990680
[TBL] [Abstract][Full Text] [Related]
8. Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene.
Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Seno T
Mol Pharmacol; 1985 Dec; 28(6):581-7. PubMed ID: 3001499
[TBL] [Abstract][Full Text] [Related]
9. Resistance to methotrexate in thymidylate synthetase-deficient mutants of cultured mouse mammary tumor FM3A cells.
Ayusawa D; Koyama H; Seno T
Cancer Res; 1981 Apr; 41(4):1497-501. PubMed ID: 6452198
[TBL] [Abstract][Full Text] [Related]
10. Thymidylate synthetase as target enzyme for the inhibitory activity of 5-substituted 2'-deoxyuridines on mouse leukemia L1210 cell growth.
De Clercq E; Balzarini J; Torrence PF; Mertes MP; Schmidt CL; Shugar D; Barr PJ; Jones AS; Verhelst G; Walker RT
Mol Pharmacol; 1981 Mar; 19(2):321-30. PubMed ID: 7231392
[No Abstract] [Full Text] [Related]
11. Antiviral, antitumor, and thymidylate synthetase inhibition studies of 5-substituted styryl derivatives of 2'-deoxyuridine and their 5'-phosphates.
De Clercq E; Balzarini J; Descamps J; Bigge CF; Chang CT; Kalaritis P; Mertes MP
Biochem Pharmacol; 1981 Mar; 30(5):495-502. PubMed ID: 6261769
[No Abstract] [Full Text] [Related]
12. Mechanisms of action of FdUMP[10]: metabolite activation and thymidylate synthase inhibition.
Bijnsdorp IV; Comijn EM; Padron JM; Gmeiner WH; Peters GJ
Oncol Rep; 2007 Jul; 18(1):287-91. PubMed ID: 17549381
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of 5-nitro-2'-deoxyuridine by in vivo inhibition of thymidylate synthetase.
Washtien W; Matsuda A; Wataya Y; Santi DV
Biochem Pharmacol; 1978; 27(22):2663-6. PubMed ID: 215163
[No Abstract] [Full Text] [Related]
14. Synthesis of 5-selenium-substituted uracil derivatives. Inhibition of thymidylate synthetase by 5-hydroseleno-2'-deoxyuridylate.
Choi S; Kalman TI; Bardos TJ
J Med Chem; 1979 Jun; 22(6):618-21. PubMed ID: 110931
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of mammalian tumour thymidylate synthetase by 5-alkylated 2'-deoxyuridine 5'-phosphates.
Rode W; Kulikowski T; Kedzierska B; Jastreboff M; Shugar D
Biochem Pharmacol; 1984 Sep; 33(17):2699-705. PubMed ID: 6466380
[TBL] [Abstract][Full Text] [Related]
16. Biochemical effects of a quinazoline inhibitor of thymidylate synthetase, N-(4-(N-(( 2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino) benzoyl)-L-glutamic acid (CB3717), on human lymphoblastoid cells.
Jackson RC; Jackman AL; Calvert AH
Biochem Pharmacol; 1983 Dec; 32(24):3783-90. PubMed ID: 6661252
[TBL] [Abstract][Full Text] [Related]
17. Strategies for the measurement of the inhibitory effects of thymidine analogs on the activity of thymidylate synthase in intact murine leukemia L1210 cells.
Balzarini J; De Clercq E
Biochim Biophys Acta; 1984 Feb; 785(1-2):36-45. PubMed ID: 6696920
[TBL] [Abstract][Full Text] [Related]
18. 5-Nitro-2'-deoxyuridine and 5-nitro-2'-deoxyuridine 5'-monophosphate: antiviral activity and inhibition of thymidylate synthetase in vivo.
De Clercq E; Descamps J; Huang GF; Torrence PF
Mol Pharmacol; 1978 May; 14(3):422-30. PubMed ID: 661811
[No Abstract] [Full Text] [Related]
19. Intracellular thymidylate synthase inhibition by trifluorothymidine in FM3A cells.
Temmink OH; Comijn EM; Fukushima M; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1491-4. PubMed ID: 15571283
[TBL] [Abstract][Full Text] [Related]
20. 5-Ethyl-2'-deoxyuridine-5'-monophosphate inhibition of the thymidylate synthetase from Escherichia coli.
Walter RD; Gauri KK
Biochem Pharmacol; 1975 May; 24(9):1025-7. PubMed ID: 1098667
[No Abstract] [Full Text] [Related]
[Next] [New Search]
